Skip to main content
logo
Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
5.04
-0.19 (-3.63%)
Jul 24, 2026, 1:57 PM EDT - Market open

Seres Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.79---144.93
Revenue Growth
-----336.33%
Gross Profit
-0.79---144.93
Operating Income
-88.79-93.97-121.32-195.1-195.1-64.49
Net Income
-19.915.70.14-113.72-113.72-65.58
Earnings Per Share
-5.180.64--17.77-46.20-14.40
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
29.8345.7730.79127.97181.34290.71
Total Debt
80.582.9791.64198.78162.5949.21
Net Cash (Debt)
-50.67-37.2-60.85-70.8218.75241.5
Net Cash Growth
-----92.23%13.46%
Net Cash Per Share
-5.58-4.19-7.83-11.063.4752.67

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-42.151.12-148.61-117.35-228.826.69
Capital Expenditures
-0.22-0.25-0.38-7.98-9.82-9.57
Free Cash Flow
-42.370.87-148.99-125.33-238.64-2.88
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%---100.00%
Operating Margin
--11910.10%----44.50%
Pretax Margin
-721.93%----45.25%
Profit Margin
-721.93%----45.25%
FCF Margin
-109.63%----1.99%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-23.25----
P/FCF Ratio
-164.39----
PS Ratio
42.89180.23---5.28